Optoacoustic Imaging in Inflammation
- PMID: 33924983
- PMCID: PMC8145174
- DOI: 10.3390/biomedicines9050483
Optoacoustic Imaging in Inflammation
Abstract
Optoacoustic or photoacoustic imaging (OAI/PAI) is a technology which enables non-invasive visualization of laser-illuminated tissue by the detection of acoustic signals. The combination of "light in" and "sound out" offers unprecedented scalability with a high penetration depth and resolution. The wide range of biomedical applications makes this technology a versatile tool for preclinical and clinical research. Particularly when imaging inflammation, the technology offers advantages over current clinical methods to diagnose, stage, and monitor physiological and pathophysiological processes. This review discusses the clinical perspective of using OAI in the context of imaging inflammation as well as in current and emerging translational applications.
Keywords: MSOT; PAI; RSOM; acute inflammation; chronic inflammation; imaging inflammation; molecular imaging; optoacoustics; photoacoustics.
Conflict of interest statement
A.P.R., M.J.W., and F.K. are co-inventors, together with iThera Medical GmbH, Munich, Germany, on an EU patent application (EP 19 163 304.9) relating to a device and a method for analyzing optoacoustic data, an optoacoustic system, and a computer program. A.P.R. and F.K. received travel support from iThera Medical GmbH, Munich, Germany. A.P.R. reports lecture fees from Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany. F.K. reports lecture fees from Siemens Healthcare GmbH, Erlangen, Germany outside the submitted work. All other authors declare no competing interests.
Figures
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
